Ryman Healthcare Ltd. (NZ:RYM)
:RYM
Total Valuation
Ryman Healthcare has a market cap or net worth of $2.30B. The enterprise value is $3.88B.
Market Cap$2.30B
Enterprise Value$3.88B
Share Statistics
Ryman Healthcare has 1,015,729,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,015,729,060
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ryman Healthcare’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -0.14%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.01
Return on Invested Capital (ROIC)-0.14%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee103.70K
Profits Per Employee-22.25K
Employee Count7,700
Asset Turnover0.07
Inventory Turnover68.02K
Valuation Ratios
The current PE Ratio of Ryman Healthcare is ―. Ryman Healthcare’s PEG ratio is 0.17.
PE Ratio―
PS Ratio2.70
PB Ratio0.53
Price to Fair Value0.53
Price to FCF7.91
Price to Operating Cash Flow7.30
PEG Ratio0.17
Income Statement
In the last 12 months, Ryman Healthcare had revenue of 798.49M and earned -171.34M in profits. Earnings per share was -0.17.
Revenue798.49M
Gross Profit-17.76M
Operating Income-17.76M
Pretax Income-177.61M
Net Income-171.34M
EBITDA24.79M
Earnings Per Share (EPS)-0.17
Cash Flow
In the last 12 months, operating cash flow was 319.68M and capital expenditures -47.30M, giving a free cash flow of 272.38M billion.
Operating Cash Flow319.68M
Free Cash Flow272.38M
Free Cash Flow per Share0.27
Dividends & Yields
Ryman Healthcare pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.80
52-Week Price Change5.99%
50-Day Moving Average2.17
200-Day Moving Average2.56
Relative Strength Index (RSI)57.85
Average Volume (3m)1.12M
Important Dates
Ryman Healthcare upcoming earnings date is Dec 2, 2026, TBA (Confirmed).
Last Earnings DateMay 25, 2026
Next Earnings DateDec 2, 2026
Ex-Dividend Date―
Financial Position
Ryman Healthcare as a current ratio of 0.55, with Debt / Equity ratio of 39.04%
Current Ratio0.55
Quick Ratio0.55
Debt to Market Cap0.73
Net Debt to EBITDA63.82
Interest Coverage Ratio-0.15
Taxes
In the past 12 months, Ryman Healthcare has paid -6.27M in taxes.
Income Tax-6.27M
Effective Tax Rate0.04
Enterprise Valuation
Ryman Healthcare EV to EBITDA ratio is 150.68, with an EV/FCF ratio of 13.71.
EV to Sales4.68
EV to EBITDA150.68
EV to Free Cash Flow13.71
EV to Operating Cash Flow11.69
Balance Sheet
Ryman Healthcare has $9.70M in cash and marketable securities with $1.59B in debt, giving a net cash position of -$1.58B billion.
Cash & Marketable Securities$9.70M
Total Debt$1.59B
Net Cash-$1.58B
Net Cash Per Share-$1.56
Tangible Book Value Per Share$4.00
Margins
Gross margin is -2.22%, with operating margin of -2.22%, and net profit margin of -21.46%.
Gross Margin-2.22%
Operating Margin-2.22%
Pretax Margin-22.24%
Net Profit Margin-21.46%
EBITDA Margin3.10%
EBIT Margin-2.22%
Analyst Forecast
The average price target for Ryman Healthcare is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target―
Price Target Upside―
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast11.86%
EPS Growth Forecast72.99%